Global Nivolumab Market Growth 2025-2031

December 2025 | 75 pages | ID: G7D7685708CEN
LP Information

Abstracts

The global Nivolumab market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

United States market for Nivolumab is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Nivolumab is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Nivolumab is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Nivolumab players cover Ono Pharmaceutical, Bristol-Myers Squibb, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “Nivolumab Industry Forecast” looks at past sales and reviews total world Nivolumab sales in 2024, providing a comprehensive analysis by region and market sector of projected Nivolumab sales for 2025 through 2031. With Nivolumab sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Nivolumab industry.

This Insight Report provides a comprehensive analysis of the global Nivolumab landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Nivolumab portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Nivolumab market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Nivolumab and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Nivolumab.

This report presents a comprehensive overview, market shares, and growth opportunities of Nivolumab market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• Injection 4mL
• Injection 10mL

Segmentation by Application:

• Unresectable Melanoma
• Metastatic Melanoma
• Metastatic Squamous NSCLC
• Classical Hodgkin Lymphoma
• Renal Cell Carcinoma
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Ono Pharmaceutical
• Bristol-Myers Squibb

Key Questions Addressed in this Report

What is the 10-year outlook for the global Nivolumab market?

What factors are driving Nivolumab market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Nivolumab market opportunities vary by end market size?

How does Nivolumab break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Nivolumab Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for Nivolumab by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for Nivolumab by Country/Region, 2020, 2024 & 2031
2.2 Nivolumab Segment by Type
  2.2.1 Injection 4mL
  2.2.2 Injection 10mL
2.3 Nivolumab Sales by Type
  2.3.1 Global Nivolumab Sales Market Share by Type (2020-2025)
  2.3.2 Global Nivolumab Revenue and Market Share by Type (2020-2025)
  2.3.3 Global Nivolumab Sale Price by Type (2020-2025)
2.4 Nivolumab Segment by Application
  2.4.1 Unresectable Melanoma
  2.4.2 Metastatic Melanoma
  2.4.3 Metastatic Squamous NSCLC
  2.4.4 Classical Hodgkin Lymphoma
  2.4.5 Renal Cell Carcinoma
  2.4.6 Others
2.5 Nivolumab Sales by Application
  2.5.1 Global Nivolumab Sale Market Share by Application (2020-2025)
  2.5.2 Global Nivolumab Revenue and Market Share by Application (2020-2025)
  2.5.3 Global Nivolumab Sale Price by Application (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global Nivolumab Breakdown Data by Company
  3.1.1 Global Nivolumab Annual Sales by Company (2020-2025)
  3.1.2 Global Nivolumab Sales Market Share by Company (2020-2025)
3.2 Global Nivolumab Annual Revenue by Company (2020-2025)
  3.2.1 Global Nivolumab Revenue by Company (2020-2025)
  3.2.2 Global Nivolumab Revenue Market Share by Company (2020-2025)
3.3 Global Nivolumab Sale Price by Company
3.4 Key Manufacturers Nivolumab Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Nivolumab Product Location Distribution
  3.4.2 Players Nivolumab Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR NIVOLUMAB BY GEOGRAPHIC REGION

4.1 World Historic Nivolumab Market Size by Geographic Region (2020-2025)
  4.1.1 Global Nivolumab Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global Nivolumab Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Nivolumab Market Size by Country/Region (2020-2025)
  4.2.1 Global Nivolumab Annual Sales by Country/Region (2020-2025)
  4.2.2 Global Nivolumab Annual Revenue by Country/Region (2020-2025)
4.3 Americas Nivolumab Sales Growth
4.4 APAC Nivolumab Sales Growth
4.5 Europe Nivolumab Sales Growth
4.6 Middle East & Africa Nivolumab Sales Growth

5 AMERICAS

5.1 Americas Nivolumab Sales by Country
  5.1.1 Americas Nivolumab Sales by Country (2020-2025)
  5.1.2 Americas Nivolumab Revenue by Country (2020-2025)
5.2 Americas Nivolumab Sales by Type (2020-2025)
5.3 Americas Nivolumab Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Nivolumab Sales by Region
  6.1.1 APAC Nivolumab Sales by Region (2020-2025)
  6.1.2 APAC Nivolumab Revenue by Region (2020-2025)
6.2 APAC Nivolumab Sales by Type (2020-2025)
6.3 APAC Nivolumab Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Nivolumab by Country
  7.1.1 Europe Nivolumab Sales by Country (2020-2025)
  7.1.2 Europe Nivolumab Revenue by Country (2020-2025)
7.2 Europe Nivolumab Sales by Type (2020-2025)
7.3 Europe Nivolumab Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Nivolumab by Country
  8.1.1 Middle East & Africa Nivolumab Sales by Country (2020-2025)
  8.1.2 Middle East & Africa Nivolumab Revenue by Country (2020-2025)
8.2 Middle East & Africa Nivolumab Sales by Type (2020-2025)
8.3 Middle East & Africa Nivolumab Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Nivolumab
10.3 Manufacturing Process Analysis of Nivolumab
10.4 Industry Chain Structure of Nivolumab

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Nivolumab Distributors
11.3 Nivolumab Customer

12 WORLD FORECAST REVIEW FOR NIVOLUMAB BY GEOGRAPHIC REGION

12.1 Global Nivolumab Market Size Forecast by Region
  12.1.1 Global Nivolumab Forecast by Region (2026-2031)
  12.1.2 Global Nivolumab Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Nivolumab Forecast by Type (2026-2031)
12.7 Global Nivolumab Forecast by Application (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 Ono Pharmaceutical
  13.1.1 Ono Pharmaceutical Company Information
  13.1.2 Ono Pharmaceutical Nivolumab Product Portfolios and Specifications
  13.1.3 Ono Pharmaceutical Nivolumab Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 Ono Pharmaceutical Main Business Overview
  13.1.5 Ono Pharmaceutical Latest Developments
13.2 Bristol-Myers Squibb
  13.2.1 Bristol-Myers Squibb Company Information
  13.2.2 Bristol-Myers Squibb Nivolumab Product Portfolios and Specifications
  13.2.3 Bristol-Myers Squibb Nivolumab Sales, Revenue, Price and Gross Margin (2020-2025)
  13.2.4 Bristol-Myers Squibb Main Business Overview
  13.2.5 Bristol-Myers Squibb Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Nivolumab Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Nivolumab Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Injection 4mL
Table 4. Major Players of Injection 10mL
Table 5. Global Nivolumab Sales by Type (2020-2025) & (K Pcs)
Table 6. Global Nivolumab Sales Market Share by Type (2020-2025)
Table 7. Global Nivolumab Revenue by Type (2020-2025) & ($ million)
Table 8. Global Nivolumab Revenue Market Share by Type (2020-2025)
Table 9. Global Nivolumab Sale Price by Type (2020-2025) & (USD/Pcs)
Table 10. Global Nivolumab Sale by Application (2020-2025) & (K Pcs)
Table 11. Global Nivolumab Sale Market Share by Application (2020-2025)
Table 12. Global Nivolumab Revenue by Application (2020-2025) & ($ million)
Table 13. Global Nivolumab Revenue Market Share by Application (2020-2025)
Table 14. Global Nivolumab Sale Price by Application (2020-2025) & (USD/Pcs)
Table 15. Global Nivolumab Sales by Company (2020-2025) & (K Pcs)
Table 16. Global Nivolumab Sales Market Share by Company (2020-2025)
Table 17. Global Nivolumab Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Nivolumab Revenue Market Share by Company (2020-2025)
Table 19. Global Nivolumab Sale Price by Company (2020-2025) & (USD/Pcs)
Table 20. Key Manufacturers Nivolumab Producing Area Distribution and Sales Area
Table 21. Players Nivolumab Products Offered
Table 22. Nivolumab Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Nivolumab Sales by Geographic Region (2020-2025) & (K Pcs)
Table 26. Global Nivolumab Sales Market Share Geographic Region (2020-2025)
Table 27. Global Nivolumab Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Nivolumab Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Nivolumab Sales by Country/Region (2020-2025) & (K Pcs)
Table 30. Global Nivolumab Sales Market Share by Country/Region (2020-2025)
Table 31. Global Nivolumab Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Nivolumab Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Nivolumab Sales by Country (2020-2025) & (K Pcs)
Table 34. Americas Nivolumab Sales Market Share by Country (2020-2025)
Table 35. Americas Nivolumab Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Nivolumab Sales by Type (2020-2025) & (K Pcs)
Table 37. Americas Nivolumab Sales by Application (2020-2025) & (K Pcs)
Table 38. APAC Nivolumab Sales by Region (2020-2025) & (K Pcs)
Table 39. APAC Nivolumab Sales Market Share by Region (2020-2025)
Table 40. APAC Nivolumab Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Nivolumab Sales by Type (2020-2025) & (K Pcs)
Table 42. APAC Nivolumab Sales by Application (2020-2025) & (K Pcs)
Table 43. Europe Nivolumab Sales by Country (2020-2025) & (K Pcs)
Table 44. Europe Nivolumab Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Nivolumab Sales by Type (2020-2025) & (K Pcs)
Table 46. Europe Nivolumab Sales by Application (2020-2025) & (K Pcs)
Table 47. Middle East & Africa Nivolumab Sales by Country (2020-2025) & (K Pcs)
Table 48. Middle East & Africa Nivolumab Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Nivolumab Sales by Type (2020-2025) & (K Pcs)
Table 50. Middle East & Africa Nivolumab Sales by Application (2020-2025) & (K Pcs)
Table 51. Key Market Drivers & Growth Opportunities of Nivolumab
Table 52. Key Market Challenges & Risks of Nivolumab
Table 53. Key Industry Trends of Nivolumab
Table 54. Nivolumab Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Nivolumab Distributors List
Table 57. Nivolumab Customer List
Table 58. Global Nivolumab Sales Forecast by Region (2026-2031) & (K Pcs)
Table 59. Global Nivolumab Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas Nivolumab Sales Forecast by Country (2026-2031) & (K Pcs)
Table 61. Americas Nivolumab Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC Nivolumab Sales Forecast by Region (2026-2031) & (K Pcs)
Table 63. APAC Nivolumab Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe Nivolumab Sales Forecast by Country (2026-2031) & (K Pcs)
Table 65. Europe Nivolumab Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Nivolumab Sales Forecast by Country (2026-2031) & (K Pcs)
Table 67. Middle East & Africa Nivolumab Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global Nivolumab Sales Forecast by Type (2026-2031) & (K Pcs)
Table 69. Global Nivolumab Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global Nivolumab Sales Forecast by Application (2026-2031) & (K Pcs)
Table 71. Global Nivolumab Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. Ono Pharmaceutical Basic Information, Nivolumab Manufacturing Base, Sales Area and Its Competitors
Table 73. Ono Pharmaceutical Nivolumab Product Portfolios and Specifications
Table 74. Ono Pharmaceutical Nivolumab Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 75. Ono Pharmaceutical Main Business
Table 76. Ono Pharmaceutical Latest Developments
Table 77. Bristol-Myers Squibb Basic Information, Nivolumab Manufacturing Base, Sales Area and Its Competitors
Table 78. Bristol-Myers Squibb Nivolumab Product Portfolios and Specifications
Table 79. Bristol-Myers Squibb Nivolumab Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 80. Bristol-Myers Squibb Main Business
Table 81. Bristol-Myers Squibb Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Nivolumab
Figure 2. Nivolumab Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Nivolumab Sales Growth Rate 2020-2031 (K Pcs)
Figure 7. Global Nivolumab Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Nivolumab Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Nivolumab Sales Market Share by Country/Region (2024)
Figure 10. Nivolumab Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Injection 4mL
Figure 12. Product Picture of Injection 10mL
Figure 13. Global Nivolumab Sales Market Share by Type in 2025
Figure 14. Global Nivolumab Revenue Market Share by Type (2020-2025)
Figure 15. Nivolumab Consumed in Unresectable Melanoma
Figure 16. Global Nivolumab Market: Unresectable Melanoma (2020-2025) & (K Pcs)
Figure 17. Nivolumab Consumed in Metastatic Melanoma
Figure 18. Global Nivolumab Market: Metastatic Melanoma (2020-2025) & (K Pcs)
Figure 19. Nivolumab Consumed in Metastatic Squamous NSCLC
Figure 20. Global Nivolumab Market: Metastatic Squamous NSCLC (2020-2025) & (K Pcs)
Figure 21. Nivolumab Consumed in Classical Hodgkin Lymphoma
Figure 22. Global Nivolumab Market: Classical Hodgkin Lymphoma (2020-2025) & (K Pcs)
Figure 23. Nivolumab Consumed in Renal Cell Carcinoma
Figure 24. Global Nivolumab Market: Renal Cell Carcinoma (2020-2025) & (K Pcs)
Figure 25. Nivolumab Consumed in Others
Figure 26. Global Nivolumab Market: Others (2020-2025) & (K Pcs)
Figure 27. Global Nivolumab Sale Market Share by Application (2024)
Figure 28. Global Nivolumab Revenue Market Share by Application in 2025
Figure 29. Nivolumab Sales by Company in 2025 (K Pcs)
Figure 30. Global Nivolumab Sales Market Share by Company in 2025
Figure 31. Nivolumab Revenue by Company in 2025 ($ millions)
Figure 32. Global Nivolumab Revenue Market Share by Company in 2025
Figure 33. Global Nivolumab Sales Market Share by Geographic Region (2020-2025)
Figure 34. Global Nivolumab Revenue Market Share by Geographic Region in 2025
Figure 35. Americas Nivolumab Sales 2020-2025 (K Pcs)
Figure 36. Americas Nivolumab Revenue 2020-2025 ($ millions)
Figure 37. APAC Nivolumab Sales 2020-2025 (K Pcs)
Figure 38. APAC Nivolumab Revenue 2020-2025 ($ millions)
Figure 39. Europe Nivolumab Sales 2020-2025 (K Pcs)
Figure 40. Europe Nivolumab Revenue 2020-2025 ($ millions)
Figure 41. Middle East & Africa Nivolumab Sales 2020-2025 (K Pcs)
Figure 42. Middle East & Africa Nivolumab Revenue 2020-2025 ($ millions)
Figure 43. Americas Nivolumab Sales Market Share by Country in 2025
Figure 44. Americas Nivolumab Revenue Market Share by Country (2020-2025)
Figure 45. Americas Nivolumab Sales Market Share by Type (2020-2025)
Figure 46. Americas Nivolumab Sales Market Share by Application (2020-2025)
Figure 47. United States Nivolumab Revenue Growth 2020-2025 ($ millions)
Figure 48. Canada Nivolumab Revenue Growth 2020-2025 ($ millions)
Figure 49. Mexico Nivolumab Revenue Growth 2020-2025 ($ millions)
Figure 50. Brazil Nivolumab Revenue Growth 2020-2025 ($ millions)
Figure 51. APAC Nivolumab Sales Market Share by Region in 2025
Figure 52. APAC Nivolumab Revenue Market Share by Region (2020-2025)
Figure 53. APAC Nivolumab Sales Market Share by Type (2020-2025)
Figure 54. APAC Nivolumab Sales Market Share by Application (2020-2025)
Figure 55. China Nivolumab Revenue Growth 2020-2025 ($ millions)
Figure 56. Japan Nivolumab Revenue Growth 2020-2025 ($ millions)
Figure 57. South Korea Nivolumab Revenue Growth 2020-2025 ($ millions)
Figure 58. Southeast Asia Nivolumab Revenue Growth 2020-2025 ($ millions)
Figure 59. India Nivolumab Revenue Growth 2020-2025 ($ millions)
Figure 60. Australia Nivolumab Revenue Growth 2020-2025 ($ millions)
Figure 61. China Taiwan Nivolumab Revenue Growth 2020-2025 ($ millions)
Figure 62. Europe Nivolumab Sales Market Share by Country in 2025
Figure 63. Europe Nivolumab Revenue Market Share by Country (2020-2025)
Figure 64. Europe Nivolumab Sales Market Share by Type (2020-2025)
Figure 65. Europe Nivolumab Sales Market Share by Application (2020-2025)
Figure 66. Germany Nivolumab Revenue Growth 2020-2025 ($ millions)
Figure 67. France Nivolumab Revenue Growth 2020-2025 ($ millions)
Figure 68. UK Nivolumab Revenue Growth 2020-2025 ($ millions)
Figure 69. Italy Nivolumab Revenue Growth 2020-2025 ($ millions)
Figure 70. Russia Nivolumab Revenue Growth 2020-2025 ($ millions)
Figure 71. Middle East & Africa Nivolumab Sales Market Share by Country (2020-2025)
Figure 72. Middle East & Africa Nivolumab Sales Market Share by Type (2020-2025)
Figure 73. Middle East & Africa Nivolumab Sales Market Share by Application (2020-2025)
Figure 74. Egypt Nivolumab Revenue Growth 2020-2025 ($ millions)
Figure 75. South Africa Nivolumab Revenue Growth 2020-2025 ($ millions)
Figure 76. Israel Nivolumab Revenue Growth 2020-2025 ($ millions)
Figure 77. Turkey Nivolumab Revenue Growth 2020-2025 ($ millions)
Figure 78. GCC Countries Nivolumab Revenue Growth 2020-2025 ($ millions)
Figure 79. Manufacturing Cost Structure Analysis of Nivolumab in 2025
Figure 80. Manufacturing Process Analysis of Nivolumab
Figure 81. Industry Chain Structure of Nivolumab
Figure 82. Channels of Distribution
Figure 83. Global Nivolumab Sales Market Forecast by Region (2026-2031)
Figure 84. Global Nivolumab Revenue Market Share Forecast by Region (2026-2031)
Figure 85. Global Nivolumab Sales Market Share Forecast by Type (2026-2031)
Figure 86. Global Nivolumab Revenue Market Share Forecast by Type (2026-2031)
Figure 87. Global Nivolumab Sales Market Share Forecast by Application (2026-2031)
Figure 88. Global Nivolumab Revenue Market Share Forecast by Application (2026-2031)